Ignite Creation Date:
2024-05-05 @ 4:58 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00355446
Status:
COMPLETED
Last Update Posted:
2007-10-17
First Post:
2006-07-20
Brief Title:
Bioavailability of Bimatoprost Ophthalmic Solution in Human Aqueous
Sponsor:
Indiana University School of Medicine
Organization:
Indiana University
Study Overview
Official Title:
Bioavailabilty of Bimatoprost Ophthalmic Solution in Human Aqueous
Status:
COMPLETED
Status Verified Date:
2007-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to assay human aqueous for bimatoprost and the presence of any metabolites especially prostaglandin analogs HypothesisBimatoprost is not metabolized to a prostaglandin F-2-alpha analog in human eyes
Bimatoprost levels in human aqueous peak approximately three hours post dosing
Bimatoprost levels in human aqueous peak approximately three hours post dosing
Detailed Description:
The purpose of this study is to assay human aqueous for bimatoprost and the presence of any metabolites especially prostaglandin analogs
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None